Physician profile
Mark E Moran
NPI 1376541326
$12,502.66
in general payments reported to CMS, 2019-2025
10 companies · $28.27 in 2025
The $28.27 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,738 · 2020: $450 · 2021: $8,016 · 2022: $1,270 · 2025: $28.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinecraft, LLC | $8,000.00 | 2021 | |
| Cerapedics INC. | $2,520.80 | 2019 | |
| Zimvie INC. | $1,256.80 | 2022 | |
| Flospine LLC | $450.00 | 2020 | |
| Orthopediatrics Corp. | $168.94 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $37.06 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $28.27 | 2025 | |
| Zimmer Biomet Holdings, INC. | $14.85 | 2019 | |
| Bioventus LLC | $13.56 | 2022 | |
| Stryker Corporation | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Moran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.